CTIS.eu › Cities › France › Saint Herblain
Saint Herblain
France
301 total trials
130 recruiting
2022-501417-31-00
5
High-risk Resected Melanoma
2022-501644-15-00
4
Mild Cognitive Impairment due to Alzheimer's Disease Alzheimer's Disea
2023-503480-42-00
10
Hospital-acquired pneumonia
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
2023-507010-27-00
5
Primary Bilateral Macronodular Adrenal Hyperplasia causing moderate Cu
2024-510602-90-00
5
Patients presenting with acute myocarditis proven by cardiac magnetic
2024-513444-28-00
5
Acute ischaemic stroke due to basilar artery occlusion.
2024-517710-15-00
4
thrombocytopenic patients undergoing cardiac surgery
2024-517749-15-00
11
Postoperative critical care
2024-517948-66-00
4
Piriformis muscle syndrome
2024-519786-22-01
9
metastatic non-small cell lung cancer (NSCLC)
2024-520414-21-00
5
Adult patients with a LVOS with large core within 9 hours of symptoms
2025-520565-51-00
5
small cell lung cancer
2025-521000-22-00
3
Patients with advanced malignancies
2025-521001-40-00
3
Advanced Malignancies and Hepatic Impairment
2025-521221-32-00
5
Advanced or Metastatic Non-Small Cell Lung Cancer
2025-521908-22-00
10
EGFR-mutated Non-small Cell Lung Cancer
2025-522790-10-00
4
Non Small Cell Lung Cancer
2025-523481-24-00
5
Participants with Progressive Supranuclear Palsy Richardson Syndrome (
2025-523576-23-00
5
Unresectable Stage III non-small cell lung cancer without progression
2025-523683-20-00
4
Postmenopausal patients with small (pT1a-b pN0) hormone receptor posit
2025-523911-13-00
5
Narcolepsy Type 1
2025-524697-42-00
5
Pleural infections
2024-519870-38-00
5
2026-05-11
Atherosclerotic cardiovascular disease (ASCVD)
Showing 1–24 of 301 trials